| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
13,406 |
10,813 |
$40K |
| 88307 |
|
369 |
365 |
$27K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,163 |
13,875 |
$21K |
| 88304 |
|
599 |
595 |
$14K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
385 |
377 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,092 |
988 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,863 |
2,419 |
$9K |
| 83880 |
|
2,337 |
2,074 |
$9K |
| 83735 |
|
7,537 |
3,212 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,883 |
1,847 |
$6K |
| 84484 |
|
4,257 |
3,575 |
$5K |
| 81001 |
|
8,765 |
8,144 |
$5K |
| 80061 |
Lipid panel |
2,031 |
1,956 |
$4K |
| 83690 |
|
4,420 |
3,971 |
$4K |
| 83605 |
|
2,901 |
2,438 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
341 |
336 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
290 |
258 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,566 |
1,550 |
$3K |
| 81025 |
|
1,081 |
1,019 |
$3K |
| 85730 |
|
2,911 |
2,306 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,577 |
1,530 |
$2K |
| 87040 |
|
1,836 |
1,600 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,933 |
1,824 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
888 |
829 |
$2K |
| 85379 |
|
1,345 |
883 |
$2K |
| 82948 |
|
4,297 |
1,693 |
$2K |
| 86780 |
|
1,306 |
1,286 |
$2K |
| 82805 |
|
497 |
262 |
$2K |
| 85610 |
|
2,986 |
2,305 |
$1K |
| 87081 |
|
1,243 |
1,183 |
$1K |
| 86803 |
|
1,117 |
1,103 |
$1K |
| 80074 |
|
118 |
116 |
$1K |
| 86769 |
|
65 |
59 |
$1K |
| 87400 |
|
756 |
739 |
$968.01 |
| 80076 |
|
716 |
398 |
$740.74 |
| 87186 |
|
609 |
575 |
$724.64 |
| 84100 |
|
1,582 |
542 |
$693.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
564 |
556 |
$681.77 |
| 85027 |
|
1,009 |
552 |
$670.01 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
98 |
98 |
$657.51 |
| 82150 |
|
594 |
578 |
$638.61 |
| 87077 |
|
516 |
487 |
$621.58 |
| 86592 |
|
260 |
257 |
$597.70 |
| 84702 |
|
1,143 |
1,069 |
$515.00 |
| 80050 |
General health panel |
725 |
711 |
$480.63 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
98 |
98 |
$466.11 |
| 86140 |
|
755 |
240 |
$430.08 |
| 82550 |
|
703 |
481 |
$390.61 |
| 80202 |
|
220 |
101 |
$377.38 |
| 84439 |
|
231 |
220 |
$354.66 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
67 |
67 |
$325.26 |
| 85007 |
|
956 |
512 |
$318.79 |
| 87070 |
|
270 |
216 |
$258.56 |
| 86635 |
|
192 |
172 |
$245.76 |
| 84145 |
|
174 |
101 |
$218.11 |
| 87486 |
|
46 |
45 |
$205.26 |
| 87581 |
|
45 |
44 |
$201.41 |
| 87205 |
|
340 |
263 |
$201.25 |
| 87807 |
|
106 |
103 |
$167.21 |
| 82140 |
|
91 |
54 |
$160.14 |
| 82247 |
|
231 |
149 |
$150.87 |
| 82248 |
|
367 |
215 |
$131.11 |
| 86038 |
|
52 |
52 |
$105.69 |
| 86141 |
|
59 |
55 |
$83.78 |
| 83615 |
|
333 |
74 |
$80.82 |
| 86701 |
|
20 |
20 |
$80.04 |
| 82728 |
|
206 |
60 |
$73.35 |
| 82043 |
|
73 |
72 |
$72.04 |
| 84703 |
|
226 |
220 |
$57.20 |
| 82010 |
|
46 |
42 |
$53.69 |
| 84481 |
|
13 |
12 |
$46.80 |
| 85652 |
|
138 |
94 |
$40.97 |
| 85651 |
|
43 |
39 |
$32.82 |
| 85018 |
|
99 |
65 |
$30.58 |
| 85014 |
|
87 |
52 |
$24.91 |
| 82553 |
|
15 |
13 |
$15.04 |
| 36415 |
Collection of venous blood by venipuncture |
1,163 |
1,055 |
$12.36 |
| 84466 |
|
15 |
13 |
$11.88 |
| 82570 |
|
14 |
12 |
$9.23 |
| 87340 |
|
13 |
12 |
$6.56 |
| 85384 |
|
24 |
14 |
$1.38 |
| 84132 |
|
40 |
17 |
$0.00 |